検索
Unicycive Therapeutics Inc
UNCYウォッチリストに追加
5.730USD
+0.450+8.52%
終値 07/02, 13:00（ET）15分遅れの株価
152.99M時価総額
損失額直近12ヶ月PER
詳細情報 Unicycive Therapeutics Inc 企業名
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Unicycive Therapeutics Incの企業情報
企業コードUNCY
会社名Unicycive Therapeutics Inc
上場日Jun 17, 2021
最高経営責任者「CEO」Gupta (Shalabh)
従業員数22
証券種類Ordinary Share
決算期末Jun 17
本社所在地4300 El Camino Real, Suite 210
都市LOS ALTOS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94022
電話番号16503840642
ウェブサイトhttps://unicycive.com/
企業コードUNCY
上場日Jun 17, 2021
最高経営責任者「CEO」Gupta (Shalabh)
Unicycive Therapeutics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
--
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
Mr. Doug Jermasek
Mr. Doug Jermasek
Executive Vice President - Corporate Strategy
Executive Vice President - Corporate Strategy
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
--
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
よくある質問
Unicycive Therapeutics Incの上位5名の株主は誰ですか？
Unicycive Therapeutics Incの上位5名の株主は以下のとおりです。Dr. Sandeep (Steve) Laumas, M.D.
Unicycive Therapeutics Inc（UNCY）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Unicycive Therapeutics Incの株式を保有している機関は75社あり、保有株式の総市場価値は約9.56Mで、全体の35.81%を占めています。2025Q4と比較して、機関の持ち株は450872.00増加しています。